bcd-063
Showing 1 - 1 of 1
Relapsing-remitting Multiple Sclerosis Trial (BCD-063, Copaxone-Teva, Placebo)
Completed
- Relapsing-remitting Multiple Sclerosis
- BCD-063
- +2 more
- (no location specified)
Sep 8, 2021